The Competition Commission of India (CCI) started a consultation process to gather views from pharma companies, doctors and other stakeholders as part of its ongoing study on the country’s pharma sector.
Anti-competition watch dog Competition Commission of India (CCI) has asked its Director General (DG) to conduct an investigation into the pricing pattern of super-specialty hospitals in and around Delhi.